Carl Icahn has called off the dogs hounding DNA-sequencing company Illumina
FortuneIcahn blamed Illumina’s management for its handling of the failed acquisition of cancer detection startup Grail Inc.
Icahn blamed Illumina’s management for its handling of the failed acquisition of cancer detection startup Grail Inc.